Target intelligence / Profile preview

Epoprostenol Receptor (IP)

Target
IP
Molecular classification
G protein-coupled receptor (GPCR)
01

Overview

The epoprostenol receptor, also known as the prostacyclin receptor or IP receptor, is a G protein-coupled receptor (GPCR) that mediates the effects of prostacyclin (PGI₂), also called epoprostenol. This receptor plays a critical role in vascular homeostasis by promoting vasodilation and inhibiting platelet aggregation.

Other names
Prostacyclin ReceptorProstaglandin I₂ receptor
02

Mechanism of action

Agonism of the IP receptor, leading to increased cAMP production and downstream signaling events, resulting in vasodilation and inhibition of platelet aggregation.

03

Biological functions

VasodilationPlatelet inhibitionRegulation of vascular toneAnti-inflammationAnti-proliferation
04

Disease associations

Pulmonary arterial hypertensionCardiovascular diseaseInflammation
05

Safety considerations

Hypotension
06

Interacting drugs

Epoprostenol

1 more in the full profile.

Beyond the preview

Go deeper on Epoprostenol Receptor (IP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epoprostenol Receptor (IP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call